Relation between serum hepatitis C virus-RNA levels and efficacy of interferon-beta therapy

Acta Paediatr Jpn. 1995 Aug;37(4):530-3. doi: 10.1111/j.1442-200x.1995.tb03370.x.

Abstract

We performed two courses of interferon-beta (IFN-beta) to a child with chronic hepatitis C. A complete response was not obtained by the first interferon treatment, however, the results of the second treatment differed from those of the first. Hepatitis C virus (HCV)-RNA remained negative and both aspartate aminotransferase and alanine aminotransferase levels remained normal after completion of the second course. From these results we estimated that HCV-RNA levels before IFN therapy could be significantly associated with the efficacy of this treatment. The serum level of HCV-RNA was 10(6) copies/50 microL before the first treatment, but was 10(3) copies/50 microL before the second course. We conclude that IFN therapy to children with hepatitis C should always be directed at providing a cure. Even if the clinical effects of the first course are minimal decreasing quantities of HCV-RNA still offer hope for cure by subsequent readministration.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antiviral Agents / therapeutic use*
  • Chronic Disease
  • Female
  • Hepacivirus / genetics*
  • Hepatitis C / therapy*
  • Hepatitis C / virology
  • Humans
  • Interferon-beta / therapeutic use*
  • RNA, Viral / blood*

Substances

  • Antiviral Agents
  • RNA, Viral
  • Interferon-beta